<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24016" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Landau-Kleffner Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Muzio</surname>
            <given-names>Maria Rosaria</given-names>
          </name>
          <aff>ASL NA3 SUD</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cascella</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Via Mariano Semmola 80100, Napoli. Italy</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Khalili</surname>
            <given-names>Yasir</given-names>
          </name>
          <aff>Virginia Commonwealth University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maria Rosaria Muzio declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Cascella declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasir Al Khalili declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24016.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Landau-Kleffner syndrome is a rare age-related epileptic encephalopathy that usually manifests itself in children aged 3 to 8 years with previously normal development. The disorder is characterized by language regression and seizures and is often associated with social cognitive deficits. This activity outlines the evaluation and management of Landau-Kleffner syndrome and reviews the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of Landau-Kleffner syndrome.</p></list-item><list-item><p>Review the evaluation of Landau-Kleffner syndrome.</p></list-item><list-item><p>Outline the treatment and management options available for Landau-Kleffner syndrome.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to advance Landau-Kleffner syndrome and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24016">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24016.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Landau-Kleffner syndrome (LKS) is a rare age-related epileptic encephalopathy, characterized by a developmental regression in the area of language, and electroencephalogram (EEG) anomalies located mainly around the temporoparietal areas. When present, the seizures consist of absence seizures or tonic-clonic episodes and occur more frequently during sleep. Behavioral disorders may form part of the clinical picture. The syndrome, described in 1957,<xref ref-type="bibr" rid="article-24016.r1">[1]</xref> is also indicated as <italic toggle="yes">acquired aphasia</italic>&#x000a0;<italic toggle="yes">with epilepsy</italic> (ICD-10, F80.3) for outlining&#x000a0;the main signs of this disease. It is considered a form of continuous spike-waves during slow sleep syndrome (CSWS), although the two syndromes have a different clinical presentation and diagnostic significance.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-24016.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology of Landau-Kleffner syndrome is not known. Structural brain injuries are very rare in patients with LKS are not related to pathophysiology. Moreover, genetic factors may be involved. For instance, the disease&#x000a0;can correlate with GRIN2A mutations (16p13.2). This gene encodes for a protein called GluN2A (also known as NR2A), which is a subunit of the N-methyl-D-aspartate (NMDA) glutamate-gated ion channel receptor. Of note, NR2A can be identified in high concentrations in brain areas crucial for&#x000a0;speech and language, whereas NMDA receptors are involved in&#x000a0;a wide range of functions related to memory and learning. Again, GRIN2A alterations have correlations with a considerable number of neurodevelopmental disorders that can include epilepsy among the clinical manifestations.<xref ref-type="bibr" rid="article-24016.r2">[2]</xref><xref ref-type="bibr" rid="article-24016.r3">[3]</xref>&#x000a0;</p>
        <p>There were suggestions regarding possible implications of autoimmune factors in the genesis of some forms of epilepsy.<xref ref-type="bibr" rid="article-24016.r4">[4]</xref>&#x000a0;Other studies have shown that in children with LKS, an increased rate of autoantibodies directed against brain-derived neurotrophic factor (BDNF) is present.<xref ref-type="bibr" rid="article-24016.r5">[5]</xref>&#x000a0;Potential involvement of the immune system and/or an inflammatory dysregulation could justify the response to corticosteroids in most cases of LKS.<xref ref-type="bibr" rid="article-24016.r6">[6]</xref></p>
      </sec>
      <sec id="article-24016.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It is difficult to express an estimate of the prevalence and incidence of the syndrome. Landau-Kleffner syndrome, indeed, is described as sporadic or limited case series. From&#x000a0;the description of the syndrome, in 1957, no more than a few hundred cases have been reported in the literature. An epidemiologic study demonstrated that the incidence of children with LKS in Japan was about 1 in a million.<xref ref-type="bibr" rid="article-24016.r7">[7]</xref> Furthermore, it emerges that males are more affected than females and that the reference age is between&#x000a0;3 and 8 years. However, documented cases also exist of younger children or&#x000a0;adolescents with the syndrome.<xref ref-type="bibr" rid="article-24016.r8">[8]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-24016.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of the syndrome presents multiple dark sides, as well as its etiology. Probably, the pathophysiology is the result of alterations of specific processes related to neurodevelopment and genetic factors involving mutations in the GRIN2A gene. There have been suggestions that language impairment results from epileptiform anomalies located in areas involved in language processing.<xref ref-type="bibr" rid="article-24016.r9">[9]</xref>&#x000a0;According to this hypothesis, when these&#x000a0;aberrations&#x000a0;develop during a phase of neural development associated with&#x000a0;effective cortical synaptogenesis and functional networks, the&#x000a0;effect&#x000a0;of these alterations may be&#x000a0;expressed as&#x000a0;language difficulties.<xref ref-type="bibr" rid="article-24016.r10">[10]</xref>&#x000a0;It is important to note that clinical manifestations (aphasia) are not strictly related, in terms of severity, to seizures. Some children have severe aphasia despite not having seizures. Thus, epileptic activity and not seizures probably correlate with language impairment and its degree.</p>
      </sec>
      <sec id="article-24016.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Although Landau-Kleffner syndrome may affect children and adolescents, the syndrome usually manifests itself in children aged 3 to 8 years with previously normal development.&#x000a0;Aphasia, EEG alterations, seizures, and behavioral disorders are the main features of the syndrome.&#x000a0;</p>
        <p>
<bold>Aphasia</bold>
</p>
        <p>In children with previously normal development, the new onset of&#x000a0;aphasia is the hallmark of the disease. In particular, aphasia initially manifests as auditory verbal aphasia (receptive aphasia) that precedes the expressive aphasia featuring difficulties in the processing or interpreting verbal and/or non-verbal sounds. Children may also express&#x000a0;babbling, neologisms, verbal perseveration, or mutism. Concerning aphasia, the typical presentation of the syndrome is characterized by a child who, despite apparently normal neurodevelopment, begins to have difficulty understanding written and spoken the language. Subsequently, over days, weeks, or months, the young patient manifests expressive difficulties along with impairment of spontaneous language that, in turn, becomes limited and altered.</p>
        <p>
<bold>Seizures&#x000a0;</bold>
</p>
        <p>Seizures occur in approximately two-thirds of individuals patients. The crises described characteristically demonstrate partial motor crises (more common), generalized clonic crises, and atypical absence seizures (e.g., eye blinking, chewing gestures, as well as lip-smacking, or slight jerking movements of the lips).&#x000a0;</p>
        <p>
<bold>Behavioral Disorders</bold>
</p>
        <p>Language regression is often associated with social cognitive deficits and behavioral disorders, such as attention deficit, hyperactivity, impulsiveness, and the tendency to get distracted. Emotional lability, anxiety, and depression, sleep disorders, working memory impairment (but not long-term memory), and hypersensitive to sound may complete this clinical picture, which can sometimes be particularly complex.<xref ref-type="bibr" rid="article-24016.r11">[11]</xref><xref ref-type="bibr" rid="article-24016.r12">[12]</xref></p>
      </sec>
      <sec id="article-24016.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of Landau-Kleffner syndrome has its basis on the anamnesis, evaluation of clinical signs, and EEG findings.</p>
        <p>
<bold>Clinical Evaluation</bold>
</p>
        <p>The acquired aphasia&#x000a0;in a child who previously had no problem is initially receptive and then involves expressive difficulties. Behavioral disorders such as hyperexcitability and hyperactivity surround the aphasia but are sometimes very marked. At this stage, the role of the pediatrician who performs the anamnesis and coordinates several specialists is very important. An audiometric examination is a requirement to rule out hearing impairment. A&#x000a0;thorough evaluation must be carried out by the child neuropsychiatrist and by speech therapists and psychomotor experts. Moreover, the pediatrician is the figure of connection with the neurophysiologist.</p>
        <p>
<bold>Sleep EEG Findings and Clinical Correlates</bold>
</p>
        <p>EEG examination during wakefulness and sleep is&#x000a0;fundamental for diagnosis. The EEG shows unilateral or bilateral activity most pronounced over posterior temporal regions around the&#x000a0;Sylvian fissure. This EEG activity&#x000a0;becomes much more widespread and intense during sleep (non-REM sleep) when it becomes characterized by an almost continuous spike-wave pattern with a frequency of 1.5 to 2.5 spikes/sec. Background EEG activity and sleep macro architecture are normal. Yet, during REM sleep, epileptic activity may partially break off, diminish, or cease.</p>
        <p>Clinically, these findings occasionally hesitate in&#x000a0;an electrical status epilepticus during sleep (ESES).&#x000a0;ESES is characterized by marked enhancement of epileptiform discharges during the transition from wake to sleep, resulting in spikes and slow (almost) continuous, bilateral, or sometimes lateralized waves. These findings are observable for a significant part of non-REM sleep. Furthermore, the ESES in Landau-Kleffner syndrome can be unilateral or bilateral.</p>
        <p>
<bold>Other Evaluations</bold>
</p>
        <p>Through a volumetric analysis using magnetic resonance (MRI), it could be possible to observe a reduction in the volume of the brain areas responsible for language development. This data, however, has no diagnostic utility but is recommended to exclude structural lesions&#x000a0;such as brain tumors. The analysis of the GRIN2A gene is not part of routine clinical procedures, although the test is available in some specialized centers. However, because in families with a GRIN2A mutation, an autosomal dominant transmission has been proposed, genetic counseling can be suggested. In some countries, such as Norway, the evaluation of serum neuronal antibodies is a recommendation before treatment.</p>
      </sec>
      <sec id="article-24016.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>While no international consensus exists on the most appropriate type of therapy, it is&#x000a0;commonly accepted that therapy should commence as soon as possible.<xref ref-type="bibr" rid="article-24016.r10">[10]</xref></p>
        <p>
<bold>Epileptic Manifestations</bold>
</p>
        <p>In the presence of a crisis&#x000a0;(usually mild and infrequent), several antiepileptic drugs are effective, and the control of convulsions is generally easy to do. Several &#x0201c;spike-suppressing&#x0201d; medications, including valproate, clobazam, levetiracetam, ethosuximide, are usually preferred. The use of carbamazepine, oxcarbazepine, phenytoin, and phenobarbital should be avoided as they can exacerbate epileptiform discharge from ESES.</p>
        <p>
<bold>Speech Therapy and Behavioral Programs</bold>
</p>
        <p>Speech therapy includes a series of patient-centered approaches aimed at the recovery of language skills. These therapies commonly use augmentative and alternative communication devices aimed at speech training. In younger children, however, this type of approach may not be effective due to poor compliance. In these cases, a therapeutic plan should provide, in its first step, the involvement of a psychomotor therapist, later supported by the speech therapist. Furthermore, psychomotricity has a fundamental value in dealing with behavioral and relational alterations.</p>
        <p>
<bold>Other Treatments</bold>
</p>
        <p>Corticosteroids (e.g., prednisone orally 1 mg/kg/day for 6 months or prednisolone orally 2 mg/kg/day for at least three months before gradual tapering) could be helpful for improvement or at least stabilization in language, cognition, and behavior skills.<xref ref-type="bibr" rid="article-24016.r13">[13]</xref>&#x000a0;Their use, also in combination with benzodiazepines (BDZs), is recommended when the epileptic activity and language impairments persist despite therapy.<xref ref-type="bibr" rid="article-24016.r14">[14]</xref> Other pharmacological attempts have been made with intravenous immunoglobulin, although the results have been unsuccessful, and the studies conducted on the topic had little power.<xref ref-type="bibr" rid="article-24016.r15">[15]</xref>&#x000a0;A ketogenic diet, calcium-channel blocking drugs, and amantadine are options that researchers also have examined.<xref ref-type="bibr" rid="article-24016.r16">[16]</xref></p>
        <p>Multiple subpial transections (MST) in the posterior temporal lobe of the dominant hemisphere is a surgical approach that tries to interrupt&#x000a0;epilepsy&#x000a0;while preserving the eloquent cortex. It consists of the transection of the horizontal corticocortical fibers while sparing the vertical cortico-subcortical fibers. In 1999, Grote et al. showed that MST might induce the restoration of language abilities in children with Landau-Kleffner syndrome.<xref ref-type="bibr" rid="article-24016.r17">[17]</xref>&#x000a0;More recently, Downes et al. have not found significant advantages with MST compared to medical therapy.<xref ref-type="bibr" rid="article-24016.r18">[18]</xref>&#x000a0;However, this latter study focused on a wider group of patients, including those with ESES.<xref ref-type="bibr" rid="article-24016.r19">[19]</xref>&#x000a0;The use of this invasive technique should be limited to severe and pharmaco-resistant cases and in the case of steroid dependency or toxicity.</p>
      </sec>
      <sec id="article-24016.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Verbal agnosia is often confused by parents as hearing loss. Moreover, the behavioral disorders related to aphasia can lead to the suspicion of a form of autistic spectrum disorder (ASD), although regressive forms of ASD show cognitive impairments in multiple domains rather than just about language. Furthermore, there might be a suspected diagnosis of conditions characterized by persistent inattention, hyperactivity, and impulsivity, such as attention deficit hyperactivity disorder (ADHD). Thus, it is mandatory to rule out a hearing loss, autism, or ADHD.</p>
        <p>On the other side, the epileptic manifestations, impose a differential diagnosis with epileptic syndromes associated with the enhancement of epileptiform activity during sleep, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Continuous&#x000a0;spike-waves during slow sleep syndrome (CSWS)</p>
          </list-item>
          <list-item>
            <p>Atypical benign partial epilepsy (ABPE)</p>
          </list-item>
          <list-item>
            <p>Early-onset benign partial epilepsy with occipital paroxysm (or Panayiotopoulos syndrome)</p>
          </list-item>
          <list-item>
            <p>Lennox-Gastaut syndrome</p>
          </list-item>
          <list-item>
            <p>Pseudo-Lennox syndrome</p>
          </list-item>
          <list-item>
            <p>Benign childhood epilepsy with centrotemporal spikes (BECTS) or rolandic epilepsy (RE)</p>
          </list-item>
        </list>
        <p>Of note, LKS, CSWS, and RE can be considered as a single and continuous spectrum of childhood epilepsies and epileptic encephalopathies (i.e., the epilepsy-aphasia spectrum) featuring acquired cognitive, behavioral and speech and/or language impairment.<xref ref-type="bibr" rid="article-24016.r2">[2]</xref> It is significant to note that apart from those affected by "epileptic encephalopathies" such as CSWS, LKS,&#x000a0;RE (regression is mild and transient), and West syndrome (regression is&#x000a0;profound and permanent), the&#x000a0;majority of children with epilepsy do not have any regression.<xref ref-type="bibr" rid="article-24016.r20">[20]</xref>&#x000a0;</p>
        <p>Finally, clinicians must also consider that aphasia can be the effect of various organic causes such as space-occupying lesions, post-traumatic effects, and infections.</p>
      </sec>
      <sec id="article-24016.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In light of the rarity of the syndrome, it is difficult to have a clear picture of its prognosis, although the pathology is&#x000a0;considered&#x000a0;a benign epileptic encephalopathy. The prognosis varies mainly about aphasia. For instance, in a retrospective analysis conducted on eleven children, only four showed no language impairment after&#x000a0;adolescence, whereas four manifested moderate language problems, and three severe language damages after more than ten years from the diagnosis.<xref ref-type="bibr" rid="article-24016.r12">[12]</xref> Of note, late-onset of aphasia, short duration of the initial receptive manifestations, and marked fluctuations in speech performances have associations with a positive outcome. Despite the limitations of the studies conducted, it is possible to deduce that language improves with treatment and at puberty, although without returning to the condition before the disease in&#x000a0;a significant percentage of subjects.&#x000a0;On the other side, concerning seizures, the prognosis is good as&#x000a0;epileptic manifestations of Landau-Kleffner syndrome are easily controlled and spontaneously regress before adolescence. Thus, the therapeutic aspect is of paramount importance, especially for addressing&#x000a0;individuals with moderate long-term language difficulties, and especially for those who, after adolescence, have a severe alteration of language.&#x000a0;</p>
      </sec>
      <sec id="article-24016.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Children with a diagnosis of Landau-Kleffner syndrome require management with an interprofessional team. Therapeutic planning and interprofessional&#x000a0;communication among the various professional figures play an essential role in improving outcomes. The professionals involved are multiple and include&#x000a0;a pediatrician who has the task of care coordinator, a child neuropsychiatrist, and a neurophysiologist. Also, a speech therapist and a psychomotor therapist (in the case of younger children) will have to carry out specific habilitation and rehabilitation programs. The pharmacist should encourage medication compliance, check for drug interactions, and alert the prescriber to medications that may exacerbate the condition. Specialty-trained neuroscience nursing staff can assist in monitoring treatment, as well as counseling the patients and/or parents. Additionally, the social worker should ensure that the patient has adequate facilities in the home and access to support services. Strategies&#x000a0;aimed at strengthening communication functions require continuous calibration according to the patient's needs; this requires dynamic coordination for enhancing team performance. These are but a few examples of how an interprofessional team can improve patient care in Landau-Kleffner syndrome. [Level 5]</p>
        <p>
<bold>Perspectives</bold>
</p>
        <p>In children with refractory epileptic encephalopathy, an investigation with cannabidiol (tetrahydrocannabinol provided as an oil-based suspension) is ongoing&#x000a0;(Phase 1, open-label dose-escalation study). Another randomized trial&#x000a0;is evaluating&#x000a0;acetazolamide (orally 8-10 mg/kg for 4-8 weeks) versus diazepam (orally 0.5 mg/kg for four weeks) in patients with CSWS and LKS. An interesting pharmacological perspective is an association between corticosteroids and BDZs. In this direction, it would be appropriate to design ad hoc studies. Among non-pharmacological strategies, Pedro et al. published a case of a patient who, after&#x000a0;11 years of pharmacological and specialized education interventions had no significant improvement and was successfully treated through a multimodal approach focused on facilitating inter-hemispheric communication.<xref ref-type="bibr" rid="article-24016.r21">[21]</xref>&#x000a0;The experimentation of new non-pharmacological multimodal approaches is certainly another option to be investigated.</p>
      </sec>
      <sec id="article-24016.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24016">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/landau-kleffner-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24016">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24016/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24016">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24016.s13">
        <title>References</title>
        <ref id="article-24016.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landau</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Kleffner</surname>
                <given-names>FR</given-names>
              </name>
            </person-group>
            <article-title>Syndrome of acquired aphasia with convulsive disorder in children. 1957.</article-title>
            <source>Neurology</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>1241</fpage>
            <page-range>1241, 8 pages following 1241</page-range>
            <pub-id pub-id-type="pmid">9867583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lesca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Rudolf</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hjalgrim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Szepetowski</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Update on the genetics of the epilepsy-aphasia spectrum and role of GRIN2A mutations.</article-title>
            <source>Epileptic Disord</source>
            <year>2019</year>
            <month>Jun</month>
            <day>01</day>
            <volume>21</volume>
            <issue>S1</issue>
            <fpage>41</fpage>
            <page-range>41-47</page-range>
            <pub-id pub-id-type="pmid">31149903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strehlow</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Heyne</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Vlaskamp</surname>
                <given-names>DRM</given-names>
              </name>
              <name>
                <surname>Marwick</surname>
                <given-names>KFM</given-names>
              </name>
              <name>
                <surname>Rudolf</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Bellescize</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Biskup</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brilstra</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Callenbach</surname>
                <given-names>PMC</given-names>
              </name>
              <name>
                <surname>Hentschel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kind</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Mignot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Platzer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rump</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Skehel</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Wyllie</surname>
                <given-names>DJA</given-names>
              </name>
              <name>
                <surname>Hardingham</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>van Ravenswaaij-Arts</surname>
                <given-names>CMA</given-names>
              </name>
              <name>
                <surname>Lesca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lemke</surname>
                <given-names>JR</given-names>
              </name>
              <collab>GRIN2A study group</collab>
            </person-group>
            <article-title>GRIN2A-related disorders: genotype and functional consequence predict phenotype.</article-title>
            <source>Brain</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>142</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-92</page-range>
            <pub-id pub-id-type="pmid">30544257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husari</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Dubey</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune Epilepsy.</article-title>
            <source>Neurotherapeutics</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>685</fpage>
            <page-range>685-702</page-range>
            <pub-id pub-id-type="pmid">31240596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Theodore</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Avanzini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Immune-mediated epilepsies.</article-title>
            <source>Epilepsia</source>
            <year>2011</year>
            <month>May</month>
            <volume>52 Suppl 3</volume>
            <issue>Suppl 3</issue>
            <fpage>5</fpage>
            <page-range>5-11</page-range>
            <pub-id pub-id-type="pmid">21542839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakker</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Catsman-Berrevoets</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Neuteboom</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of a hybrid corticosteroid treatment regimen on refractory childhood seizures and a review of other corticosteroid treatments.</article-title>
            <source>Eur J Paediatr Neurol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>553</fpage>
            <page-range>553-60</page-range>
            <pub-id pub-id-type="pmid">25976064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inagaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ohta</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological study of Landau-Kleffner syndrome (LKS) in Japan.</article-title>
            <source>Brain Dev</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>284</fpage>
            <page-range>284-6</page-range>
            <pub-id pub-id-type="pmid">23706409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caraballo</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Cejas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chamorro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kaltenmeier</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Fortini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soprano</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Landau-Kleffner syndrome: a study of 29 patients.</article-title>
            <source>Seizure</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>98</fpage>
            <page-range>98-104</page-range>
            <pub-id pub-id-type="pmid">24315829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stefanatos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Changing perspectives on Landau-Kleffner syndrome.</article-title>
            <source>Clin Neuropsychol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>963</fpage>
            <page-range>963-88</page-range>
            <pub-id pub-id-type="pmid">21955111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hughes</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>A review of the relationships between Landau-Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike-waves during sleep.</article-title>
            <source>Epilepsy Behav</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-53</page-range>
            <pub-id pub-id-type="pmid">21242107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Besag</surname>
                <given-names>FMC</given-names>
              </name>
              <name>
                <surname>Vasey</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Social cognition and psychopathology in childhood and adolescence.</article-title>
            <source>Epilepsy Behav</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>100</volume>
            <issue>Pt B</issue>
            <fpage>106210</fpage>
            <pub-id pub-id-type="pmid">31196824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cockerell</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>B&#x000f8;lling</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nakken</surname>
                <given-names>KO</given-names>
              </name>
            </person-group>
            <article-title>Landau-Kleffner syndrome in Norway: long-term prognosis and experiences with the health services and educational systems.</article-title>
            <source>Epilepsy Behav</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-9</page-range>
            <pub-id pub-id-type="pmid">21514895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinclair</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids for the treatment of Landau-kleffner syndrome and continuous spike-wave discharge during sleep.</article-title>
            <source>Pediatr Neurol</source>
            <year>2005</year>
            <month>May</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>300</fpage>
            <page-range>300-6</page-range>
            <pub-id pub-id-type="pmid">15866429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Escobar Fern&#x000e1;ndez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Coccolo G&#x000f3;ngora</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>V&#x000e1;zquez L&#x000f3;pez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Polo Arrondo</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Miranda Herrero</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Barredo Valderrama</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Castro de Castro</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Continuous spike-waves during slow-wave sleep: Experience during 20 years].</article-title>
            <source>An Pediatr (Engl Ed)</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>91</volume>
            <issue>3</issue>
            <fpage>180</fpage>
            <page-range>180-188</page-range>
            <pub-id pub-id-type="pmid">30772272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arts</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Aarsen</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Scheltens-de Boer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Catsman-Berrevoets</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Landau-Kleffner syndrome and CSWS syndrome: treatment with intravenous immunoglobulins.</article-title>
            <source>Epilepsia</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>50 Suppl 7</volume>
            <fpage>55</fpage>
            <page-range>55-8</page-range>
            <pub-id pub-id-type="pmid">19682053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Eliyan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sankar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Amantadine: A new treatment for refractory electrical status epilepticus in sleep.</article-title>
            <source>Epilepsy Behav</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>84</volume>
            <fpage>74</fpage>
            <page-range>74-78</page-range>
            <pub-id pub-id-type="pmid">29754107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grote</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Van Slyke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hoeppner</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Language outcome following multiple subpial transection for Landau-Kleffner syndrome.</article-title>
            <source>Brain</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>122 ( Pt 3)</volume>
            <fpage>561</fpage>
            <page-range>561-6</page-range>
            <pub-id pub-id-type="pmid">10094262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Downes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Greenaway</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Helen Cross</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jolleff</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Harkness</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kaliakatsos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neville</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Outcome following multiple subpial transection in Landau-Kleffner syndrome and related regression.</article-title>
            <source>Epilepsia</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>56</volume>
            <issue>11</issue>
            <fpage>1760</fpage>
            <page-range>1760-6</page-range>
            <pub-id pub-id-type="pmid">26337264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wongwiangjunt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kotagal</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Comment on outcome following multiple subpial transection in Landau-Kleffner syndrome and related regression.</article-title>
            <source>Epilepsia</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>674</fpage>
            <pub-id pub-id-type="pmid">27041135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camfield</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Camfield</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Regression in children with epilepsy.</article-title>
            <source>Neurosci Biobehav Rev</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>96</volume>
            <fpage>210</fpage>
            <page-range>210-218</page-range>
            <pub-id pub-id-type="pmid">30537476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24016.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pedro</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Leisman</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Hemispheric integrative therapy in Landau-Kleffner syndrome: applications for rehabilitation sciences.</article-title>
            <source>Int J Neurosci</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>115</volume>
            <issue>8</issue>
            <fpage>1227</fpage>
            <page-range>1227-38</page-range>
            <pub-id pub-id-type="pmid">16040364</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
